Due to Brexit, the Medicines and Healthcare products Regulatory Agency (MHRA) has had to develop its own procedures separate from the European Medicines Agency (EMA). What new guidance has the MHRA released? Join Darshan Kulkarni as he talks with...
There is growing pressure being placed on pharmaceutical companies to make their clinical trials more transparent. Despite this pressure, there remain privacy concerns about publicizing clinical research data. How can companies successfully balance...
Transparency, or the practice of disclosing clinical trial data, is highly important in clinical research. What happens when companies decide to not publish all of their clinical trial results, and fall out of compliance with the FDAA? FDA...
What are the four branches of patient centricity, and how can they apply to your company? In this episode, Darshan Kulkarni explains how companies can foster patient centricity through privacy, transparency, innovation and access. Plus, how the FDA...
Often, clinical trial results do not end up being disclosed. How can companies address this lack of transparency in clinical research? Darshan Kulkarni investigates the four ways in which health care companies can improve data transparency while...
Patient centricity has become a major focal point for companies in 2019. What are four ways life science companies can incorporate patient centricity? Join Darshan Kulkarni as he discusses how health care companies can implement more patient-centric...